Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

MCC Update 07-16-13

AHCMCC2 - Image - 560x80 - Update banner

Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, sherm019@umn.edu, by noon on Friday for publication the following Tuesday.

NOTE: Update will be published bi-weekly until September 10, 2013, with the exception of the July 30 issue, due to vacation schedules.

 

July 16, 2013

 

In This Issue

 

News

Professional Education

Events

Funding Opportunities


 

News  

Members in the news

Paul Pentel, M.D., Ph.D., and Mark LeSage, PhD., Prevention and Etiology Program, are mentioned in a Nanowerk story for the role they are playing in the search for a nanotechnology fix for nicotine dependence.

Angela Panoskaltsis-Mortari, Ph.D., Transplant Biology and Therapy Program, was quoted in a Nature article about tissue engineering.

Elizabeth Pluhar, D.V.M., Ph.D., Immunology Program, was interviewed about the
new treatments for dogs with brain tumors being developed at the University of Minnesota on  KSTP-TV and KSTC-TV. 

Poster Registration opens for 4th Annual Masonic Cancer Center Research Symposium
Registration is now open for the Fourth Annual Research Symposium to be held on October 16, 2013 in the Great Hall of Coffman Memorial Union from 10:30 a.m. to 3:30 p.m. The symposium will include a presentation by Douglas Yee, M.D., Director of the Masonic Cancer Center, two poster sessions, and a keynote speaker, Carl June, M.D., the B.J. Kennedy Lecturer in Medical Oncology, Richard W. Vague Professor in Immunotherapy, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania.

Students, staff, postdocs and PIs are encouraged to participate and submit an abstract for the poster session. The poster format is changing this year. Visit the website for more information. A subcommittee will select the best abstract from each research program area for a special opportunity to have lunch with our keynote speaker.

Registration deadline August 30, 2013. Register online.
 

Masonic Cancer Center to adopt Enterprise Oncore Clinical Trials Management System
The University of Minnesota CTSI has purchased an Enterprise license for OnCore, the Clinical Trials Management System used by the Masonic Cancer Center.  This will allow cancer center users to benefit from the enhanced financial and bio-specimen capabilities.  The Masonic Cancer Center will be transitioning to the Enterprise version of the software and transferring administrative responsibility to the CTSI.   The MCC clinical trials office staff and the informatics team have completed extensive testing to ensure a smooth transition. The schedule is as follows:

  • 7 a.m., July 19, 2013: MCC OnCore will be offline.
  • 7 a.m., July 22, 2013: CTSI Enterprise OnCore will be available.

Users will receive an email with the new URL once the transition is complete and should update their bookmarks with the new URL at that time.  Passwords and user names will not change. There will be NO access to OnCore July 19-22. Users should prepare accordingly for any scheduled patient visits. 

The MCC Oncology Informatics and Services team is committed to make this transition as transparent and smooth to our users as possible. If there are technical issues, a backup plan to revert to the MCC OnCore is in place.

For the general help desk send email to CC-ONCORE-HELP@LISTS.UMN.EDU  
For CENIC help desk send email to CENIC-HELP@LISTS.UMN.EDU

Applications are being accepted for the Community Research Institute (CRI) in October 2013
The CRI is a 6-week series of workshops that include lecture-style instruction, small group activities, and networking opportunities. In addition to the workshops, Institute participants will have the chance to meet with university and community-based research consultants to discuss specific issues in community-engaged research. All participating organizations will also receive a $1,000 mini-grant for their participation in the program.

The CRI is geared specifically for leaders and staff from community-based organizations that are seeking to enhance their skills in research methodology (including evaluation) and use research to enhance their programming and service delivery. Institute participants need not have prior research experience and can be at any level of research expertise. Participants should have a proposed project that they would like to work on during the institute.

The Office of Community Engagement for Health of the Clinical and Translational Science Institute (CTSI) along with the Center for Health Equity and the Program in Health Disparities Research are co-sponsoring this effort and are now accepting applications for participants in the Institute. There are a limited number of slots available. Organizations can send up to three people to participate in the Institute.  Visit the CTSI website to learn more or apply. Completed applications are due by 4:00 p.m. on August 8, 2013.

Back to top

Professional Education

August 8, 2013: Comparative Oncology Seminar
12-1 p.m., 280 VDL
Summer Scholars presentations by Frances Phan (Modiano lab), Rachel Spencer (Dickerson lab), and Chris Thomson (Pluhar lab).

August 19, 2013: Cancer and Health Disparities Summer Internship Program Poster Presentation Session
12-1 p.m., 717 Delaware Street, room 105

September 16, 2013: 10th Annual Women’s Health Research Conference – “Optimizing Women’s Health Through a Life Course Approach”
McNamara Alumni Center, 200 Oak St, Minneapolis, Minn.
Keynote Speakers:
Paula Braveman, M.D., M.P.H., Professor, Family and Community Medicine, University of California-San Francisco
Janet Rich-Edwards, ScD, M.P.H., Investigator, Nurses’ Health Study, Harvard School of Public Health

To register visit the website.

September 26-27, 2013: The Second Minnesota Neuro-Oncology Symposium: Basic Discovery Accelerating Groundbreaking Brain Tumor Therapy
McNamara Alumni Center, 200 Oak Street SE, Minneapolis, Minn.
Presented by: The Brain Tumor Program, Masonic Cancer Center, University of Minnesota, University of Minnesota Medical Center, Fairview, University of Minnesota Amplatz Children’s Hospital

For more information and to register visit the website.

Visit the Education and Training Opportunities web page for more conference and special lecture listings.

Back to top

Events 

July 22, 2013: Rein in Sarcoma Party in the Park
Cafesjian’s Carousel and Como Park Visitor Center, St. Paul, Minn.
This annual event, hosted by the Karen Wyckoff Rein in Sarcoma Foundation, benefits sarcoma research at the Masonic Cancer Center, University of Minnesota. Join us as we celebrate the 13th anniversary of this event with a magical evening of music, entertainment, and family fun. Visit www.reininsarcoma.org.

September 7, 2013: HOM Silent No More Walk/Run for Ovarian Cancer
Rosland Park, Edina

September 18, 2013: Save the Date for Varsity Team Rally III!
6-9 p.m., Cancer/Cardiovascular Building, Biomedical Discovery District

Visit the Community Events and Outreach page for more information.

Back to top

Funding Opportunities

News and Notices

Notice of Intent to Publish a Funding Opportunity Announcement for NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)
(NOT-LM-13-003)
National Cancer Institute
FOA is expected to be published in August 2013 with an application deadline in November 2013.
Funding: $25,000/year total costs

Funding Opportunities

Prostate and Urologic Cancer Translational Workgroup Pilot Project Awards (PDF)
Masonic Cancer Center, Urologic Cancer Translational Working Group and Institute for Prostate and Urologic Cancers
Deadline: August 15, 2013
Funding: Type A (single investigator): Up to $30,000, Type B (collaborative studies): Up to $50,000

The Winston and Maxine Wallin Neuroscience Discovery Fund (PDF)
Academic Health Center
Deadline:September 12, 2013
Funding: Up to $150,000/one year
To advance the work of neuroscientists leading innovative, groundbreaking and novel research. Question about the funding opportunity, application process or eligibility can be directed to Tucker LeBien (lebie001@umn.edu), Tim Ebner (ebner001@umn.edu), or Jerry Vitek (vitek004@umn.edu).
 

2014 Young Investigator Grants
Lymphoma Research Foundation (LRF)
Application receipt Dates: September 5, 2013
Funding:

  • Postdoctoral Fellowship: $105,000 over 2 years
  • Clinical Investigator Career Development Award: $75,000/year for 3 years

Career Development Awards in Tobacco Control Regulatory Research
National Cancer Institute
Application Receipt Date(s): October 02, 2013
See specific RFA for budget limitations.

(RFA-OD-13-013)

New Initiatives and Requests for Applications
American Cancer Society
Application Receipt Date: October 15, 2013

Funding: $100,000 total costs over 2 years

Funding: $60,000/year direct costs for up to 2 years

Funding: $200,000/year direct costs for up to 4 years

Research Scholar Grants
American Cancer Society
Application Receipt Date(s): October 15, 2013
Funding: $165,000/year direct costs for up to 4 years

Mentored Research Scholar Grants
American Cancer Society
Application Receipt Date(s): October 15, 2013
Funding: Awards are for up to five years and for up to $135,000 per year (direct costs), plus 8% allowable indirect costs. A maximum of $10,000 per year for the mentor(s) (regardless of the number of mentors) is included in the $135,000.

Postdoctoral Fellowships
American Cancer Society
Application Receipt Date(s): October 15, 2013
Funding: Awards may be for three years with progressive stipends of $48,000, $50,000, and $52,000 per year, plus a $4,000 per year fellowship allowance

Research to Characterize and Reduce Stigma to Improve Health
R01 (PA-13-248)
R03 (PA-13-247)
R21 (PA-13-246)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.  Standard cycle dates.
Funding: Standard limits apply

Tobacco Control Regulatory Research
R01 (RFA-OD-13-011)
R03 (RFA-OD-13-012)
R21 (RFA-OD-13-010)
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
Application Receipt Date(s): January 15, 2014; June 17, 2014, January 16, 2015
Funding: R01 - $499,999 direct costs per year; standard limits for R03 and R21 applications.

Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.

Back to top

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on August 5, 2013